ASO Author Reflections: The Survival Advantage Persists: Benefit of Adjuvant Chemotherapy in Resected, Stage IA Pancreatic Cancer

被引：0
|
作者：
Turner, Kevin M. [1 ]
Patel, Sameer H. [2 ]
机构：
[1] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH USA
[2] Univ Cincinnati, Dept Surg, Div Surg Oncol, Coll Med, Cincinnati, OH 45221 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2022年 / 29卷 / 07期
关键词：
D O I：
10.1245/s10434-022-11650-w
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：4620 / 4621
页数：2
相关论文
共 50 条
  • [41] ASO Author Reflections: Adjuvant Chemoradiation in Resected Biliary Cancers-Insights and Implications
    Dominguez, Dana A.
    Melstrom, Laleh G.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (08) : 4942 - 4943
  • [42] Survival Benefit of Adjuvant Chemotherapy in Resected Squamous Carcinoma of the Gallbladder
    Olecki, Elizabeth
    Brahmbhatt, Rushin
    Peng, June
    Vining, Charles
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S192 - S192
  • [43] ASO Author Reflections: Intraoperative Anticancer Therapy for Resected Gastric Cancer
    Shouki Bazarbashi
    Annals of Surgical Oncology, 2023, 30 : 433 - 434
  • [44] ASO Author Reflections: Intraoperative Anticancer Therapy for Resected Gastric Cancer
    Bazarbashi, Shouki
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (01) : 433 - 434
  • [45] ASO Author Reflections: The Trilogy of Cancer, Inflammation, and Survival
    Al Lawati, Yaseen
    Ferri, Lorenzo
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (11) : 4420 - 4421
  • [46] ASO Author Reflections: The Trilogy of Cancer, Inflammation, and Survival
    Yaseen Al Lawati
    Lorenzo Ferri
    Annals of Surgical Oncology, 2020, 27 : 4420 - 4421
  • [47] The benefit of adjuvant radiotherapy on overall survival in resected stage I to II pancreatic cancer: A propensity-adjusted analysis
    Lin, Zhuang-Bin
    Song, Jian-Yuan
    Li, An-Chuan
    Chen, Cheng
    Huang, Xiao-Xue
    Xu, Ben-Hua
    PLOS ONE, 2020, 15 (12):
  • [48] Adjuvant Chemotherapy for Resected Intrahepatic Cholangiocarcinoma Confers No Survival Advantage.
    Sharib, Jeremy
    Liu, Annie
    McIntyre, Sarah
    Rhodin, Kristen E.
    Kemeny, Nancy E.
    Cercek, Andrea
    Harding, James J.
    Abou-Alfa, Ghassan K.
    Soares, Kevin C.
    Wei, Alice C.
    Drebin, Jeffrey
    Kingham, T. Peter
    D'Angelica, Michael I.
    Uronis, Hope
    Strickler, John H.
    Morse, Michael A.
    Zani, Sabino
    Allen, Peter J.
    Jarnagin, William R.
    Lidsky, Michael E.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S10 - S10
  • [49] Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage.
    Sharib, Jeremy
    Liu, Annie
    McIntyre, Sarah Margaret Helena
    Rhodin, Kristen Elizabeth
    Kemeny, Nancy E.
    Cercek, Andrea
    Harding, James J.
    Abou-Alfa, Ghassan K.
    Soares, Kevin
    Wei, Alice Chia-chi
    Drebin, Jeffrey A.
    Kingham, T. Peter
    D'Angelica, Michael Ian
    Uronis, Hope Elizabeth
    Strickler, John H.
    Morse, Michael
    Zani, Sabino
    Allen, Peter J.
    Jarnagin, William R.
    Lidsky, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 560 - 560
  • [50] Delay in Adjuvant Chemotherapy and Survival Advantage in Stage III Colon Cancer Discussion
    Wise, Paul
    Efron, Jonathan
    Foley, Eugene F.
    Migaly, John
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 226 (04) : 678 - +
12345